Arcellx Rings the Opening Bell

ABOUT THIS EVENT

Arcellx, Inc. (Nasdaq: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, visits the Nasdaq MarketSite in Times Square. 

In honor of the occasion, Rami Elghandour, Chairman and Chief Executive Officer of Arcellx rings the Opening Bell.
 

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore